Ethyl 4-Bromo-1H-Pyrrole-2-Carboxylate

How Do Palladium-Catalysed Conditions Preserve the Ethyl Ester During Biaryl Construction?

Cross-coupling at the 4-bromo position of ethyl 4-bromo-1H-pyrrole-2-carboxylate to generate pharmaceutically relevant biaryl architectures places the ethyl ester under constant threat of nucleophilic cleavage. The ester moiety survives Suzuki-Miyaura sequences only when the aqueous base is buffered and delivered at strictly controlled temperatures. In a representative protocol targeting a JAK2 inhibitor intermediate, the bromide (1.0 eq) is combined with a boronic acid (1.15 eq) in degassed THF/H₂O (4:1 v/v). Potassium carbonate (2.0 eq) is charged as the base, but the potassium ion must be sequestered by adding 0.3 eq of 18-crown-6 to suppress ester saponification; the mixture is maintained at 55–60°C for 14 h. Pd(PPh₃)₄ at 0.015 eq provides adequate turnover while minimising palladium black precipitation. Monitoring by inline ReactIR at 1720 cm⁻¹ (carbonyl stretch) confirms ester integrity throughout the reaction. Post-workup, the crude biaryl ester is purified via flash chromatography on silica gel (eluent heptane/EtOAc 8:1) and recrystallised from isopropanol/water to yield off-white needles with purity exceeding 99.3 area% by HPLC (column: C18, 5 μm, 250 × 4.6 mm; mobile phase MeCN/0.1% TFA; flow 1.0 mL/min; detection UV 254 nm; retention time 12.7 min). Residual palladium is quantitated by ICP-MS per USP 〈233〉 and maintained below 10 ppm to meet ICH Q3D oral concentration limits. The produced intermediate is directly progressed to amide bond formation with 2-amino-4-chloropyrimidine, delivering a hinge-binding motif of Janus kinase inhibitors. Operational boundaries are narrow: if the internal temperature exceeds 65°C, ester hydrolysis accelerates and generates the inactive carboxylic acid, which complexes palladium and stalls catalysis. Replacement of THF with dioxane raises the boiling point but retards oxidative addition; mixed solvent systems containing DMF are avoided because DMF promotes N-arylation of the pyrrole NH by the bromoarene, forming an intractable by-product that co-elutes with the target compound on silica gel TLC (R_f difference < 0.05). On pilot scale (50 L jacketed glass reactor, Hastelloy C-276), exotherm management requires a slow addition of the boronic acid solution over 45 min under nitrogen with jacket setpoint at 45°C before ramping to reaction temperature. Batch-to-batch variations in boronic acid anhydride content are corrected by adjusting the equivalent charge based on ¹H NMR assay. Accepted standard for release: ≥98.5% purity, single impurity ≤0.5%, residual solvents tested per USP 〈467〉 (THF ≤720 ppm, isopropanol ≤5000 ppm), and visual colour not darker than Y5 per EP 2.2.2.

The following table summarises a comparative ligand screen conducted under otherwise identical Schlenk conditions (scale 5.0 mmol substrate, 55°C, 14 h, K₂CO₃/18-crown-6). Entries represent isolated yields after chromatography and HPLC purity of the combined crystallisation crop.

Regioselective Deprotonation Trajectories in Agrochemical Intermediate Production

Halogen-metal exchange at the 4-position of the pyrrole is kinetically disfavoured relative to deprotonation at the 5-position when the NH proton is inadequately protected. In the gram-scale synthesis of a chlorfenapyr analogue, ethyl 4-bromo-1H-pyrrole-2-carboxylate (1.0 eq) is first treated with NaH (1.05 eq) in THF at 0°C for 30 min to generate the N-sodio species. Cooling to -78°C and adding n-BuLi (1.1 eq, 2.5 M in hexanes) cleanly lithiates the 5-position through directed ortho-metalation (DoM) controlled by the ester group. Quenching with N,N-dimethylformamide (DMF, 3.0 eq) delivers the 5-formyl derivative in 78% isolated yield after silica gel chromatography (EtOAc/hexane 1:6). The formyl group is subsequently condensed with 4-chlorobenzylamine to construct the pyrrole oxime ether pharmacophore. This sequence circumvents the need for transient N-protection/deprotection and exploits the electronic bias of the ester lone pair directing group. On a 20 L cryogenic unit with jacket capable of -85°C, the lithiation step requires dropwise BuLi addition at a rate not exceeding 1.5 mL/min to maintain internal temperature below -70°C. If the temperature rises above -65°C, lithiation at the bromine-bearing carbon competes, causing bromide elimination and generation of the pyrrolyne intermediate, which dimerises to a deep-blue tar that fouls the reactor’s bottom drain valve. The exothermic quench with DMF must be pre-cooled to -60°C and diluted with THF (1:1 v/v) to avoid localised hot spots. Post-quench, the mixture is allowed to warm to -20°C over 3 h before aqueous ammonium chloride workup. Compliance for agrochemical intermediate shipment follows FAO Specification Guidelines for Pesticide Impurities; the batch is tested for halogenated dioxin-like side products by GC-MS (according to EPA Method 8270E) with a reporting limit of 0.1 ppm. Residual lithium is checked by AAS and must fall below 50 ppm to prevent downstream catalyst poisoning in subsequent condensation steps. The 5-formyl intermediate is stored under argon at 2–8°C with a shelf-life of 90 days before peroxide formation necessitates re-distillation. Combinations with strong Lewis acids (e.g., AlCl₃) must be avoided because the ester oxygen coordinates Al(III), triggering ring-opening of the pyrrole and complete decomposition within hours at ambient temperature.

Electropolymerisation of 4-bromopyrrole-2-carboxylate monomers onto indium tin oxide (ITO)-coated glass substrates yields conductive films whose redox activity depends critically on the integrity of the ester side chain during the anodic process. The monomer, ethyl 4-bromo-1H-pyrrole-2-carboxylate (10 mM), is dissolved in anhydrous acetonitrile containing tetrabutylammonium hexafluorophosphate (TBAPF₆, 0.1 M) as supporting electrolyte. The solution is sparged with nitrogen for 20 min prior to cyclic voltammetry (CV) scanning from -0.5 V to +1.4 V versus Ag/Ag⁺ at a scan rate of 50 mV/s using a three-electrode cell (working electrode: ITO 2 cm²; counter: Pt wire). Nucleation of the polymer film initiates at the first oxidative peak near +1.1 V, and subsequent cycles build a uniform adherent coating. The ester substituent lowers the oxidation potential relative to unsubstituted pyrrole by approximately 0.15 V, narrowing the processing window; over-oxidation above +1.4 V irreversibly hydrolyses the ester and introduces carbonyl defects into the conjugated backbone, measurable as a new IR band at 1685 cm⁻¹. After 20 CV cycles, the film is rinsed with acetonitrile and dried. Sheet resistance is determined by four-point probe per ASTM D4496-21, with acceptable values of 1–5 kΩ/sq for a thickness of 200 ± 30 nm (measured by stylus profilometry). The bromide termini of the film serve as post-polymerisation grafting sites: immersion in a 2-thiopheneboronic acid solution with Pd(PPh₃)₄ permits Suzuki surface functionalisation, changing the work function by 0.3 eV as gauged by Kelvin probe force microscopy. Such modified electrodes are under evaluation for organic thin-film transistor (OTFT) drain-source contacts. Major failure mode: ambient relative humidity above 60% during electropolymerisation promotes nucleophilic attack of water on the ester, causing loss of electrochemical activity within 48 h of storage. Therefore, glovebox conditions (< 1 ppm H₂O, < 1 ppm O₂) are mandatory. No published data from full OTFT device fabrication cycles are available for this specific ester derivative; reported mobilities for analogous 3-alkylpyrrole copolymers place expectations in the range 10⁻³–10⁻² cm²/V·s.

When the 4-Bromo Substituent Directs Lithiation in Cross-Coupling Ligand Scaffolds

Transformation of the pyrrole core into monodentate phosphine ligands proceeds through a lithium-halogen exchange that must be executed without alkylithium addition to the ester carbonyl. A solution of ethyl 4-bromo-1H-pyrrole-2-carboxylate (1.0 eq) in Et₂O is treated at -100°C (liquid N₂/hexane bath) with t-BuLi (2.2 eq, 1.7 M in pentane) over 20 min. The ultralow temperature suppresses nucleophilic attack at the ester; even at -95°C, conversion to the tert-butyl ketone side product exceeds 12%. After 40 min of lithiation, chlorodiphenylphosphine (1.05 eq) is added as a solution in Et₂O, and the mixture is warmed to room temperature overnight. The resulting 2-ethoxycarbonyl-4-diphenylphosphino-1H-pyrrole is isolated as a white solid after deoxygenated aqueous workup and flash chromatography (EtOAc/hexanes 1:20 to 1:4 gradient) under nitrogen to prevent phosphine oxidation. Typical yield: 61%. This phosphine ligand, when complexed with Pd₂(dba)₃, catalyses the amination of 2-chloropyridine with morpholine at 80°C in toluene with 0.5 mol% palladium loading and achieves full conversion within 2 h. The ester handle can be further derivatised to the carboxylic acid (LiOH, THF/H₂O, 60°C, 6 h) and subsequently coupled to aminopropyl-functionalised silica for heterogenised catalyst systems. Buchwald-Hartwig coupling conditions must avoid amines with pK_a of conjugate acid above 11 because such bases catalyse ester aminolysis, leading to amide contaminants that coordinate palladium and reduce catalyst turnover number. Purity specifications for the phosphine ligand as a specialty building block: ≥97% purity (³¹P NMR, single resonance at -15.3 ppm), ≤0.5% phosphine oxide, water content by Karl Fischer < 200 ppm. Storage is under argon in amber vials at -20°C with a retest date of 12 months. Desiccants must be avoided if they contain Lewis-acidic sites (e.g., silica gel desiccant sachets) that can catalyse ester cleavage upon prolonged contact.

Pyrolle-2-Carboxylate as Proline Bioisostere: Solid-Phase Peptide Conjugation Parameters

Incorporation of pyrrole-based amino acid surrogates into bioactive peptides begins with quantitative saponification of the ethyl ester. Ethyl 4-bromo-1H-pyrrole-2-carboxylate (1.0 eq) suspended in 1:1 THF/water with LiOH·H₂O (2.5 eq) is stirred at 50°C for 16 h, yielding the corresponding carboxylic acid as a beige powder after acidification and extraction (EtOAc). This acid is loaded onto Rink amide AM resin pre-swollen in DMF with HATU (4.0 eq) and DIPEA (8.0 eq) coupling at room temperature for 3 h. The 4-bromo substituent remains untouched under these conditions, providing a handle for on-resin diversification via Suzuki or Sonogashira coupling prior to global deprotection and cleavage. Peptide elongation employs standard Fmoc chemistry: deprotection with 20% piperidine in DMF confirms coupling by Kaiser test (negative after 5 min). The resulting pyrrole-2-carbonyl residues function as constrained proline mimics, inducing a cis-amide preference of approximately 70% measured by ¹H NMR integration of the diagnostic α-proton signals (DMSO-d₆). Terminal peptides incorporating this scaffold have been tested as inhibitors of the NS2B-NS3 protease from dengue virus; IC₅₀ values correlate with the torsional restraint imposed by the pyrrole ring. Manufacturing quality for pharmaceutical lead compounds: end-product purity determined at 220 nm HPLC (≥98.0% area), trifluoroacetic acid content (from cleavage cocktail) below 0.1% by ion chromatography, and endotoxin level < 0.25 EU/mg using LAL kinetic chromogenic assay per USP 〈85〉. The batch record must document absence of free hydrazine (derived from resin cleavage scavengers) at a level below 50 ppm by GC headspace. Processing on a multi-gram scale suffers from poor swelling characteristics once the pyrrole residue accounts for > 30% of the peptide mass; DMF supplemented with 20% N-methylpyrrolidone restores resin volume. One documented pitfall: the 4-bromo handle partially debrominates (8–15%) during extended (> 48 h) exposure to DIPEA at room temperature, so on-resin metal-catalysed steps are initiated immediately after loading.

Functionalisation via Sonogashira cross-coupling introduces an alkyne handle onto ethyl 4-bromo-1H-pyrrole-2-carboxylate for Cu(I)-catalysed azide-alkyne cycloaddition (CuAAC) probe assembly. The bromide (1.0 eq) is combined with trimethylsilylacetylene (2.0 eq), Pd(PPh₃)₂Cl₂ (0.02 eq), CuI (0.04 eq), and triethylamine (3.0 eq) in dry THF under nitrogen at 50°C for 6 h. The TMS protecting group is cleaved in situ by addition of TBAF (1.1 eq, 1.0 M in THF) at 0°C, and the terminal alkyne is extracted into ethyl acetate. The crude product requires column chromatography with EtOAc/hexane (1:5) containing 1% triethylamine to neutralise silica acidity, which otherwise promotes protodebromination of the pyrrole and regenerates the starting material. Isolated yield of the acetylene intermediate averages 74%. Immediate conjugation with an azide-functionalised biotin derivative (1.05 eq) using CuSO₄·5H₂O (0.1 eq) and sodium ascorbate (0.2 eq) in 1:1 t-BuOH/H₂O yields the biotinylated pyrrole probe in 82% isolated yield after precipitation. LC-MS confirmation requires a single peak (ESI+) with mass error < 5 ppm. Relative quantum yield of the pyrrole fluorophore is modest (Φ_F ~ 0.12 in methanol, reference standard quinine sulfate), sufficient for streptavidin blot detection at 1 μg/mL but inadequate for single-molecule imaging. Degradation studies indicate that the alkyne-pyrrole conjugate darkens upon exposure to ambient laboratory light, forming a non-fluorescent polymer within 72 h; all handling and chromatography steps must be conducted under low-actinic yellow lamps. Triethylamine content in the final solid must be confirmed by headspace GC to be < 100 ppm to avoid amine–copper complexes that quench fluorescence. Published stability data in biological assay buffers: in PBS at pH 7.4 and 37°C, the probe shows a half-life of 8 h before ester hydrolysis liberates the free acid, which exhibits a 30% decrease in protein-binding affinity. This hydrolysis imposes a strict time limit on bioconjugation experiments and precludes long-term storage in aqueous solution.